Harvard Bioscience Inc (HBIO) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $0.60
• Market Cap: $27.00M
• EPS: $-1.25
• 52-Week High: $0.95
• 52-Week Low: $0.28

Market Sentiment

Harvard Bioscience Inc currently has a Bullish sentiment score of 0.33.

About Harvard Bioscience Inc

Harvard Bioscience, Inc. is a leading global provider of innovative technologies and services that support fundamental research and drug development, focusing on preclinical testing and discovery. Headquartered in Holliston, Massachusetts, the company specializes in creating sophisticated instruments and apparatus that facilitate scientific exploration and enhance the efficiency of research processes across various biomedical disciplines. With a commitment to advancing life sciences, Harvard ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Harvard Bioscience Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HBIO pay dividends?

Harvard Bioscience Inc (HBIO) does not currently pay a regular dividend.

What is HBIO's market cap?

Harvard Bioscience Inc (HBIO) has a market capitalization of $27.00M with a current stock price of $0.60.